RELEASE

Brand Owner (click to sort) Address Description
PROREDI EXPERA SPECIALTY SOLUTIONS 600 Thilmany Road Kaukauna WI 54130 Release, interleaving, grease resistant, grease proof and wrapping papers for use in the food processing and food service industries;
RE-LEASE LITTLE MOON ESSENTIALS 301 W. Hallandale Beach Boulevard Hallandale Beach FL 33009 RELEASE;Body lotions; body oils; non-medicated skin oils; bath oils; essential oils; massage oil; body sprays; body powders; non-medicated body rubs for massage; body scrub; lip balms; non-medicated soaps; non-medicated salves; non-medicated balms for use on skin; body creams; non-medicated foot lotions; non-medicated foot soaks; kits composed of combinations of the foregoing; all of the foregoing for non-professional use and excluding hair care products, hair straighteners and relaxers;
RELEAZ PYTHAGORAS SYSTEMS LTD Voukourestiou 11 GR-106 71 Athens Greece RELEASE;Real estate services; financial and monetary services, and banking; valuation services;Advertising, marketing and promotional services; auctioneering services; business assistance, management and administrative services;The wording RELEAZ has no meaning in a foreign language.;Scientific and technological services; design services; information technology consultancy services;
RELEEZ Zofchak, Albert 6 Gulfstream Blvd. Matawan NJ 07747 release;methylesters of coconut oil in formulations for truck cleaning compounds;
RELESE Volunteer Lawyers for Justice 90 Mulberry Street Newark NJ 07102 RELEASE;Color is not claimed as a feature of the mark.;Providing information relating to legal affairs and representation, namely, providing pro bono legal consultation and advice;
ROLEASE SW (DELAWARE) INC. PROVIDENCE RI RELEASE;RUBBER COVERED ROLLS FOR MACHINERY;
ZERO RELEASE ADVANCED POLYMER SYSTEMS 3696 HAVEN AVENUE REDWOOD CITY CA 94063 0 RELEASE;POLYMER RESIN BEADS USED IN THE MANUFACTURE OF SKIN PROTECTION PREPARATIONS;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility, for example celecoxib, in an immediate-release fraction and a controlled-release, slow-release, programmed-release, timed-release, pulse-release, sustained-release or extended-release fraction. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.